Testing a new ultrasound for liver fat in MASLD patients
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult under 80 years old.
- You have a condition called MASLD or MASH (fatty liver disease with or without inflammation).
- You have already had or are scheduled for a special MRI that measures liver fat (MRI-PDFF) or liver stiffness (MRE).
- You do not have any active medical implants (like pacemakers or metal clips).
- You do not have a history of severe liver damage (decompensated cirrhosis) or liver cancer.
- You are not pregnant, breastfeeding, or unable to give your own consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
This study uses advanced ultrasound imaging and artificial intelligence to assess heart health in people with fatty liver disease (a condition where fat builds up in the liver). The goal is to better manage heart disease risk in these patients.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
Hear when a new Metabolic Syndrome X trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.